-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Thursday's After-Market Session
Share
Listen to the news

Gainers

  • Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market session. The market value of their outstanding shares is at $1.6 million.
  • Modular Medical (NASDAQ:MODD) stock rose 16.81% to $4.22. The company's market cap stands at $26.9 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock increased by 9.64% to $2.5. The market value of their outstanding shares is at $2.4 million.
  • Enlivex (NASDAQ:ENLV) shares moved upwards by 5.9% to $1.56. The market value of their outstanding shares is at $26.4 million.
  • Kairos Pharma (AMEX:KAPA) stock moved upwards by 5.06% to $0.25. The company's market cap stands at $6.1 million.
  • Accuray (NASDAQ:ARAY) shares moved upwards by 4.92% to $0.28. The market value of their outstanding shares is at $31.5 million.

Losers

  • Beyond Air (NASDAQ:XAIR) shares fell 20.7% to $4.52 during Thursday's after-market session. The company's market cap stands at $4.8 million.
  • Kazia Therapeutics (NASDAQ:KZIA) stock decreased by 15.98% to $14.2. The company's market cap stands at $166.8 million.
  • Attovia Therapeutics (NASDAQ:ATTO) stock fell 5.69% to $20.24.
  • ABVC BioPharma (NASDAQ:ABVC) shares fell 5.69% to $0.75. The market value of their outstanding shares is at $18.9 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) stock fell 5.16% to $3.68. The market value of their outstanding shares is at $2.1 million.
  • 60 Degrees (NASDAQ:SXTP) shares declined by 3.78% to $1.02. The company's market cap stands at $3.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending